Showing results (91-100 of 259) with videos related to
Sort By:
Pageof 26
Annals of the Rheumatic Diseases|April 1, 1985
Serum C-reactive protein measurement in the detection of intercurrent infection in Oriental patients with systemic lupus erythematosusC R Hind, S C Ng, P H Feng, et al.Acta Medica Scandinavica|January 1, 1982
Serum amyloid P-component and C-reactive protein in serum of healthy Icelanders and members of an Icelandic family with macroglobulinaemiaO Jensson, O G Björnsson, A Arnason, et al.Journal of the Neurological Sciences|March 1, 1981
Epileptic discharges produced in monkeys by injection of spleen cells from rabbits immunised with monkey brainM L Baltz, G Ettlinger, K Parrish, et al.Biochimica Et Biophysica Acta|February 18, 1982
Calcium-dependent aggregation of human serum amyloid P componentM L Baltz, F C De Beer, A Feinstein, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1981
Agglutination of complement-coated erythrocytes by serum amyloid P-componentC L Hutchcraft, H Gewurz, B Hansen, et al.Journal of Internal Medicine|October 1, 2008
C-reactive protein and coronary heart disease: a critical reviewJ P Casas, T Shah, A D Hingorani, et al.FEBS Letters|May 17, 2000
Molecular chaperone properties of serum amyloid P componentA R Coker, A Purvis, D Baker, et al.Immunology|October 1, 1986
Isolation and characterization of guinea-pig serum amyloid P componentS Maudsley, C R Hind, E A Munn, et al.Clinical and Experimental Immunology|September 1, 1984
'Amyloid degrading activity' of human serum, an in vitro clearing effect which does not involve degradation of amyloid fibrilsD Caspi, M L Baltz, A Feinstein, et al.Clinical and Experimental Immunology|September 1, 1984
The failure of ascorbic acid therapy to alter the induction or remission of murine amyloidosisM L Baltz, D Caspi, B E Glatthaar, et al.Pageof 26